Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972621 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a New Viscoelastic for Cataract Surgery
A NA study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT00972621 is a NA study that has completed, run by Abbott Medical Optics. The registered enrollment target is 400 participants.
The verdict
NCT00972621, a NA study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of a new opthalmic viscoelastic material for the use in cataract surgery. The new viscoelastic will be compared to a currently marketed viscoelastic material.
Interventions
- DEVICE Vitrax II
- DEVICE Viscoat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2009-09-30 |
| Est. Completion | 2010-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00972621
The ClinicalTrials.gov registry entry for NCT00972621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Optics, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitrax II is the first listed.
NCT00972621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00972621 about?
NCT00972621 is a clinical study titled "Clinical Evaluation of a New Viscoelastic for Cataract Surgery". The purpose of this study is to evaluate the safety and effectiveness of a new opthalmic viscoelastic material for the use in cataract surgery. The new viscoelastic will be compared to a currently marketed viscoelastic material.
What is the current status of trial NCT00972621?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2009-09-30. Estimated completion is 2010-11-30.
What interventions are being tested in trial NCT00972621?
The interventions under investigation include: Vitrax II (DEVICE), Viscoat (DEVICE).
Who is sponsoring clinical trial NCT00972621?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.